Patent details

EP3322804 Title: NUCLEASE-INDEPENDENT TARGETED GENE EDITING PLATFORM AND USES THEREOF

Basic Information

Publication number:
EP3322804
PCT Application Number:
US2016042413
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168252294
PCT Publication Number:
WO2017011721
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NUCLEASE-INDEPENDENT TARGETED GENE EDITING PLATFORM AND USES THEREOF
French Title of Invention:
PLATE-FORME D'ÉDITION GÉNIQUE CIBLÉE SANS NUCLÉASE ET UTILISATIONS DE CELLE-CI
German Title of Invention:
NUKLEASE-UNABHÄNGIGE GEZIELTE GENEDITIERUNGSPLATTFORM UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
15/07/2016
Grant date:
01/09/2021
EP Publication Date:
23/05/2018
PCT Publication Date:
19/01/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/09/2021
EP B1 Publication Date:
01/09/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/07/2022
Expiration date:
15/07/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/08/2021
 
 

Name:
Rutgers, The State University of New Jersey
Address:
83 Somerset Street, New Brunswick, NJ 08901, United States (US)

Inventor

1

Name:
JIN, Shengkan
Address:
United States (US)

2

Name:
COLLANTES, Juan-Carlos
Address:
United States (US)

Priority

Priority Number:
201562192876 P
Priority Date:
15/07/2015
Priority Country:
United States (US)

Classification

IPC classification:
C12N 15/00; C12N 15/87; A61K 48/00; C07H 21/04;

Publication

European Patent Bulletin

Issue number:
202135
Publication date:
01/09/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages